Results are comparable with other published studies, but are still unsatisfactory for many splenectomy patients. Vaccination rates must be improved and more information given to patients and GPs to allow for appropriate follow-up care.
T he spleen is an important component of the body's defences against many infections, and the adverse consequences of its removal have become increasingly apparent over the last 4-5 decades. Asplenic individuals have major difficulties in coping with specific infections, especially those involving encapsulated bacteria, such as Streptococcus pneumoniae, and are at increased risk of serious sepsis, which may be fatal. The overall incidence of septicaemia is low in adults, but death rates from overwhelming post-splenectomy sepsis (OPSI) have been reported to be up to 600 times greater than in the general population, with an estimated life-time risk for OPSI of 5%. 1 Much attention has focused recently on highlighting the risks faced by asplenic patients, and on producing guidance for the prevention of OPSI. 2, 3 The 2001 guidelines are shown in Table 1 .
Despite all such efforts, reports of OPSI continue to occur. 4 Therefore, we decided to audit the current practice in our hospital to determine whether guidelines are being followed for immunisation and antibiotic prophylaxis.
Patients and Methods
The hospital records of consecutive patients undergoing Cases were identified using theatre and pathology records. Information regarding indication for splenectomy, date of surgery, vaccination and antibiotic prophylaxis was recorded from each set of notes. In addition, we looked for evidence that the patients' general practitioners (GPs) had been informed of splenectomy.
Results

Patients
A total of 76 patients underwent splenectomy during the 5-year period of whom 43 were male. The age range was 12-90 years, but only one patient was under 16 years at the time of surgery.
Indications
Of the 76 procedures, 55 were defined as non-elective (72%), either because they were done as an emergency (e.g. traumatic rupture), or because splenectomy had not been anticipated at the beginning of the procedure (e.g. iatrogenic trauma to the spleen during laparotomy).
The commonest indications for splenectomy were iatrogenic trauma (n = 24) and traumatic rupture (n = 20). In 6 of these 44 cases, partial splenectomy was performed in an attempt to preserve some functioning spleen and, therefore, reduce the risk of post-splenectomy complications. Other indications were splenectomy during radical surgery for carcinoma (n = 8), immune thrombocytopenic purpura (n = 6) or autoimmune haemolytic anaemia (n = 3), splenic cyst (n = 3), splenomegaly due to non-Hodgkin's lymphoma (n = 3), chronic lymphocytic leukaemia (n = 1) or myeloproliferative disorder (n = 2), staging of lymphoma (n = 1), chronic pancreatitis (n = 2), spontaneous rupture of splenic artery (n = 1), and diagnostic splenectomy (n = 2) as summarised in Figure 1 .
Vaccination history
Of the 76 cases, 55 (72%) were vaccinated (30 patients received Pneumovax, HIB and Mengivac vaccines, 15 received Pneumovax and HIB, and 10 received Pneumovax alone). Of those patients undergoing elective splenectomy (n = 21), vaccination was administered to 18 AN One of the patients undergoing partial splenectomy (n = 6) was vaccinated (Fig. 2) .
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Antibiotic prophylaxis
Overall, 72 patients survived to hospital discharge. Hospital records indicated that 45 patients (63%) were discharged on penicillin or equivalent prophylaxis. In one of these, the patient was given instructions to continue the antibiotic for 2 months only. Of patients undergoing elective splenectomy (n = 21), 18 were sent home on antibiotic prophylaxis (86%), whereas of non-elective splenectomy patients (n = 51), 27 (53%) received appropriate prophylaxis. None of the 6 patients undergoing partial splenectomy received antibiotic prophylaxis.
Communication to GP
In the notes of 58 of the 72 surviving patients (81%), there was adequate documentation that the GP had been informed that the patient had undergone splenectomy. GPs were more likely to be informed that their patient had undergone splenectomy when the operation was elective (20 out of 21 patients, 95%) than if it was non-elective (36 out of 51 surviving patients, 71%).
Discussion
These audit findings are not dissimilar to other audits of post-splenectomy prophylaxis published recently. Brigden et al. 14 reported that only 68% of patients in their survey received pneumococcal vaccination. A similar vaccination rate was observed in a Danish study by Ejstrud et al., 15 with the lowest rate of vaccination occurring in patients splenectomised during radical cancer surgery or for iatrogenic trauma. Finally, a Scottish audit showed that only 37.4% of splenectomised patients were both vaccinated and given antibiotic prophylaxis according to published guidelines. 16 Our audit of patients undergoing splenectomy over a 5-year period shows that we also are falling short of published recommendations, 2, 3 both in terms of immunisation and prescribing of prophylactic antibiotics. Only 72% of patients received vaccination, and in 18% of these only the pneumococcal vaccine was administered. The 1996 guidelines 2 suggested that both Pneumovax and HIB vaccines should be administered to all patients, with the meningococcal polysaccharide A+C (Mengivac) being reserved for patients travelling to areas where the A+C strains predominate. The recent up-date to the BCSH guidelines suggests that patients not previously immunised should now receive the new meningococcal C conjugate vaccine. 3 Prophylactic antibiotics were administered to 63% of patients; in one case they were given with the advice that they only be continued for 2 months. This does not conform to the advice in the BCSH guidelines which recommend life-long penicillin prophylaxis. 2, 3 There is increasing evidence that the risk of OPSI persists for years after splenectomy. 4 The risk is greater for those splenectomised for haematological malignancy, but all asplenic patients should receive optimal advice and protection whatever the underlying aetiology. Antibiotic prophylaxis is especially important when one considers that Pneumovax offers protection against only 75% of infecting strains 4 and OPSI episodes classified as vaccine failures have been described. 6, 7 Furthermore a recent study showed that a programme of pneumococcal vaccination and prophylactic antibiotics prevented OPSI in a population of 280 children for an average of 4.3 years after splenectomy. 8 Concerns raised about universal and life-long penicillin prophylaxis include: (i) a lack of good clinical data to confirm its efficacy, 9 (ii) the emergence of penicillin resistance amongst pneumococcal strains in some parts of the world, 10 (iii) non-compliance of patients prescribed long-term penicillin; and (iv) documented incidents of failure of penicillin prophylaxis to prevent OPSI despite the responsible organism being sensitive to penicillin in vitro. 4 This has led some to advocate a policy of issuing patients with a supply of antibiotics (e.g. amoxycillin) for self-administration at the first signs of infection. 11 However, a recent survey showed that only two of 62 asplenic patients not taking prophylactic penicillin had a home supply of antibiotics for this purpose. 4 In 6 patients in the emergency group, partial splenectomy was performed: only one of these patients was vaccinated, and 0/6 received antibiotic prophylaxis. It was, however, documented in the notes of these patients that prophylaxis was 'not necessary'. There is some evidence that splenic reticulo-endothelial function can be preserved by partial splenectomy, provided that at least 25% of splenic tissue is preserved, 12, 13 but some authors recommend a more cautious approach, at least in children, and that pneumococcal and HIB vaccinations should be given along with antibiotic prophylaxis until such a time that splenic function can be assessed. 18 It is evident that vaccination rates, antibiotic prophylaxis and communication with the GP were all lower in the non-elective group than in the elective group.
Finally, although not a subject of this audit, it is also critical that patients are made aware that they are more susceptible to infection and that, despite appropriate measures, breakthrough infection may occur. It is strongly AN AUDIT OF POST-SPLENECTOMY PROPHYLAXIS -ARE WE FOLLOWING THE GUIDELINES? recommended that they be given written information and carry a card or bracelet to alert health care professionals to the risk of overwhelming infection.
Conclusions
In common with other reports, the data show that compliance with post-splenectomy prophylaxis needs to be improved, and that the problem is particularly significant in those patients undergoing non-elective splenectomy. There should be 100% vaccination rates, and patients should be discharged with antibiotics and adequate information as to how and when to use them. The education and awareness of appropriate teams to this problem must be enhanced to improve treatment to those patients whose spleens are removed.
